COMMUNIQUÉS West-GlobeNewswire

Cellectar and Orano Med Announce Collaboration to Develop New Phospholipid Drug Conjugate

01/08/2018 - 14:30

MADISON, Wis. and COURBEVOIE, France, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of [...]

AzurRx BioPharma to Present at the 2018 Cannacord Genuity 38th Annual Growth Conference (August 9th)

01/08/2018 - 14:30

BROOKLYN, N.Y., Aug. 01, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]

Pure Global Cannabis Poised To Launch Canada's First Multi-Ponic Cannabis Farm -- CFN Media

01/08/2018 - 14:30

SEATTLE, Aug. 01, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]

RedHill Biopharma Elaborates on Its Announced Positive Top-Line Results from Phase III Study of RHB-104 in Crohn’s Disease

01/08/2018 - 14:16

TEL-AVIV, Israel and RALEIGH, N.C., Aug. 01, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

GTX Corp Signs Agreement and Forms Alliance with Autism Society of America

01/08/2018 - 14:14

LOS ANGELES, Aug. 01, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO) (“the Company”), a pioneer in the field of wearable GPS human and asset tracking systems and wandering assistive technology, today announced the [...]

Organovo Announces Appointment of Steven G. Hughes, M.D. as Chief Medical Officer

01/08/2018 - 14:05

SAN DIEGO, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that Steven G. Hughes has been named Chief Medical Officer. Dr. Hughes is an industry veteran who brings [...]

Catalyst Pharmaceuticals to Hold Second Quarter Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 8th, 2018

01/08/2018 - 14:03

CORAL GABLES, Fla., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]

Foamix Pharmaceuticals to Announce Second Quarter Financial Results on August 8

01/08/2018 - 14:00

REHOVOT, Israel, and BRIDGEWATER, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]

Pieris Pharmaceuticals to Host Second Quarter 2018 Investor Call and Corporate Update on August 9, 2018

01/08/2018 - 14:00

BOSTON, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) , a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for cancer, [...]

Andrea Hartong, CNOR, CLNC is Elected to the American Health Council’s Nurse Board

01/08/2018 - 14:00

NEW YORK, Aug. 01, 2018 (GLOBE NEWSWIRE) -- The American Health Council proudly announces the election of Andrea Hartong, CNOR, CLNC to their Nursing Board for her examples of healthcare excellence. For the past 20 [...]

Osiris Therapeutics, Inc. to Re-list on The Nasdaq Global Market on August 1, 2018

01/08/2018 - 14:00

COLUMBIA, Md., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, [...]

Next Generation nVNS Therapy gammaCore Sapphire™ Now Available for Patients with Migraine and Episodic Cluster Headache in United States

01/08/2018 - 14:00

Innovative technology provides patients with convenient, easy-to-use treatment option without the potential side effects associated with commonly prescribed medicines BASKING RIDGE, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE [...]

VBL Therapeutics to Report Second Quarter 2018 Financial Results on August 16

01/08/2018 - 14:00

TEL AVIV, Israel, Aug. 01, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Chimerix to Announce Second Quarter 2018 Financial Results on August 8, 2018

01/08/2018 - 14:00

DURHAM, N.C., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that it will host a live conference call [...]

Selecta Biosciences Announces Date of Second Quarter 2018 Financial Results Conference Call

01/08/2018 - 14:00

WATERTOWN, Mass., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]

Kannalife Sciences Finalizes Share Exchange Agreement with TYG Solutions Corp.

01/08/2018 - 14:00

NEW YORK, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc. (“Kannalife”), a bio-pharmaceutical and phyto-medical company, is pleased to announce the completion of a share exchange transaction with TYG [...]

Progressive Care Earns Coveted LegitScript Certification Verifying PharmCo Pharmacy is a Safe and Credible Online Health Resource

01/08/2018 - 14:00

MIAMI, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that its subsidiary, PharmCo, LLC , has received certification [...]

Zogenix to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 6

01/08/2018 - 14:00

EMERYVILLE, Calif., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that it [...]

Atara Biotherapeutics Announces Second Quarter 2018 Financial Results and Recent Operational Progress

01/08/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]